COMPANY
CEO Message
KHAV is a vaccine, therapeutics R&D and CRO company that contributes to human
and animal health through the development of next-generation vaccines.
CEO Song Chang-sun 
KHAV is a leading company in one-health vaccine development and CRO business.
Including CEO Song Chang-sun, 70% of researchers have developed the original technology for one-health vaccines.
Including CEO Song Chang-sun, 70% of researchers have developed the original technology for one-health vaccines.
- KHAV CO. ,Ltd Chairman & CEO
- Prof. of college of Veterinary Medicine at Konkuk University
- President of Korean Society for Zoonoses
- President of Korean society of poultry science
- Commissioner of National Institute of Wildlife Disease Control
- Commissioner of Korean Animal and Plant Quarantine Agency Epidemiology Committee
- Commissioner of Korean Animal and Plant Quarantine Agency – Central livestock quarantine council
- Commissioner of Korea Disease Control and Prevention Agency – Interagency infectious disease R&D committee
- Doctor : The University of Tokyo graduate school
- Master : Konkuk University Veterinary Medicine graduate scho
- Bachelor : Konkuk University Veterinary Medicine